NovantaNOVT
About: Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.
Employees: 2,900
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
91% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 22
14% more repeat investments, than reductions
Existing positions increased: 104 | Existing positions reduced: 91
9% more capital invested
Capital invested by funds: $5.84B [Q2] → $6.37B (+$533M) [Q3]
6% more funds holding
Funds holding: 268 [Q2] → 284 (+16) [Q3]
0% more funds holding in top 10
Funds holding in top 10: 2 [Q2] → 2 (+0) [Q3]
0.52% less ownership
Funds ownership: 99.71% [Q2] → 99.2% (-0.52%) [Q3]
55% less call options, than puts
Call options by funds: $6.07M | Put options by funds: $13.5M
Research analyst outlook
We haven’t received any recent analyst ratings for NOVT.
Financial journalist opinion









